HCPCS Level II code J1756 denotes an injection of iron sucrose, billed per 1 mg, used for intravenous iron replacement therapy. This code is significant nationally because intravenous iron is commonly administered across outpatient infusion centers, physician offices, and hospital outpatient departments to manage iron deficiency and iron-deficiency anemia when oral therapy is inadequate or not tolerated. Proper coding of J1756 affects drug utilization reporting, clinical documentation, and payer reimbursement for a high-cost, frequently used parenteral medication.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for intravenous iron sucrose, common sites of service, and what to expect in billing practice for a per-milligram drug code. The publication also outlines typical benchmarks and payment considerations, common modifier use (listed separately), and areas where policy updates or payer-specific requirements may influence claims processing. Practical takeaways include how J1756 maps to therapeutic administration, the importance of accurate dosing and documentation, and where to look for payer-specific guidance. Data not available in the input is explicitly noted where applicable.